Selected Papers from the Tanawwo Workshop on Clinical Research in Precision Medicine, Rare Diseases, and Pharmacogenomics (Doha, Qatar, 2025)
A special issue of Biomedicines (ISSN 2227-9059). This special issue belongs to the section "Neurobiology and Clinical Neuroscience".
Deadline for manuscript submissions: 30 April 2026 | Viewed by 171
Special Issue Editors
2. Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA 02115, USA
Interests: neuromodulation; pain perception modulation; neurophysiology; neuroplasticity
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
This Special Issue of Biomedicines is dedicated to selected papers from the Tanawwo Workshop on Clinical Research in Precision Medicine, Rare Diseases, and Pharmacogenomics, held on December 8–11, 2025 at Qatar University, Doha, Qatar.
Organized by the Qatar Precision Health Institute (QPHI) in partnership with the Principles and Practice of Clinical Research Program (ECE department, Harvard TH Chan School of Public Health) and Qatar University, this four-day workshop provided a unique platform for multidisciplinary training and discussion at the intersection of genomics, clinical research, and innovation.
The program addressed methodological foundations and cutting-edge advances in the following areas:
- Clinical trial design in precision medicine and rare diseases;
- Pharmacogenomics and individualized therapy;
- Multi-omics and big data integration in clinical research;
- Artificial intelligence and digital health applications in trial methodology;
- Patient registries, adaptive and platform trials;
- Global perspectives on ethics, regulation, and governance (including WHO frameworks);
- Translational pipelines from bench to bedside in precision medicine.
This Special Issue seeks to capture the advances, methodologies, and innovations presented and discussed during the workshop. All participants are encouraged to submit extended full manuscripts for peer-reviewed publication in this Special Issue (with a 20% discount on the publication fee). All submissions will undergo MDPI’s standard peer review procedure. In addition, submissions from others that are not associated with this conference but with themes focusing on related topics are also welcome.
We look forward to receiving your contributions and thank you for supporting this important initiative at the intersection of precision health, genomics, and clinical research.
Prof. Dr. Felipe Fregni
Dr. Radja Messai Badji
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- precision medicine
- rare diseases
- pharmacogenomics
- adaptive and platform trials
- multi-omics integration
- artificial intelligence in clinical research
- big data and digital health
- translational medicine
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
